Stay updated on Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check42 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check49 days agoChange DetectedA new link has been added providing information about a study of Ramucirumab in combination with Paclitaxel for gastric cancer, presented by Eli Lilly and Company.SummaryDifference0.7%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check63 days agoChange DetectedThe website has been updated to include a new type of intervention in version 2.14.0, while the previous version 2.13.3 has removed the type of intervention and a link to a study about Ramucirumab.SummaryDifference0.8%
Stay in the know with updates to Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page.